BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6390538)

  • 1. Neutron and gamma dose distribution for tandem, tandem and ovoid and plaque for intracavitary 252Cf therapy of cervix carcinoma.
    Maruyama Y; Tai DL; Beach JL
    Radiat Med; 1983; 1(3):230-6. PubMed ID: 6390538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cure of cervical cancer using 252Cf neutron brachytherapy.
    Maruyama Y; van Nagell JR; Yoneda J; Donaldson ES; Gallion HH; Higgins R; Kryscio RJ
    Strahlenther Onkol; 1990 May; 166(5):317-21. PubMed ID: 2190346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of neutron/gamma-ray dose ratios in intracavitary 252Cf neutron therapy.
    Tai DL; Maruyama Y
    Radiology; 1978 Sep; 128(3):795-7. PubMed ID: 674658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study.
    Tacev T; Ptácková B; Strnad V
    Strahlenther Onkol; 2003 Jun; 179(6):377-84. PubMed ID: 12789463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reoxygenation of tumors of the uterine cervix during combined radiotherapy using low dose gamma-neutron irradiation with californium-252].
    Tacev T; Rasovská O; Strnad V; Krystof V; Prokes B; Vacek A
    Cesk Radiol; 1989 Mar; 43(2):125-35. PubMed ID: 2731302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic dosimetry for Cf-252 neutron brachytherapy of pelvic cancer.
    Maruyama Y; Beach JL; Hazle J; Ashtari M; Schroy CB; Olson MH
    Int J Radiat Oncol Biol Phys; 1985 May; 11(5):927-35. PubMed ID: 3921501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically effective doses from californium-252 intracavitary applications.
    Iyer PS
    Strahlentherapie; 1975 Feb; 149(2):185-7. PubMed ID: 806142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in flow cytometric DNA profiles induced by californium-252 neutron brachytherapy in squamocellular carcinomas of the uterine cervix.
    Tacev T; Zaloudík J; Janáková L; Vagunda V
    Neoplasma; 1998; 45(2):96-101. PubMed ID: 9687890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of 252Cf sources for neutron radiotherapy with and without augmentation by boron neutron capture therapy.
    Yanch JC; Zamenhof RG
    Radiat Res; 1992 Sep; 131(3):249-56. PubMed ID: 1438684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Californium-252: isotope for modern radiotherapy of cervix, uterine and vaginal carcinomas.
    Maruyama Y; Beach JL; van Nagell JR
    Strahlentherapie; 1984 Jun; 160(6):373-81. PubMed ID: 6464041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regression of cervix uteri neoplasms in combined radiotherapy using low dose gamma-neutron irradiation].
    Tacev T; Prokes B; Krystof V; Strnad V; Rasovská O; Ptácková B
    Cesk Radiol; 1989 Aug; 43(4):258-66. PubMed ID: 2791122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.
    Maruyama Y; Mesina J; Yudelev M; Wierzbicki J; Deppe G; Porter AT
    Strahlenther Onkol; 1994 May; 170(5):253-63. PubMed ID: 8197547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid clearance of advanced pelvic carcinomas by low dose rate 252Cf neutron therapy.
    Maruyama Y
    Radiology; 1979 Nov; 133(2):473-5. PubMed ID: 493540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neutron therapy of endometrial cancer using californium-252 sources of high activity].
    Kiseleva VN; Savinova VF; Mar'ina LA; Chekhonadskiĭ VN
    Vopr Onkol; 1988; 34(9):1070-4. PubMed ID: 3188432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patterns of the formation of a dosage field in arranging 252Cf and 60Co sources in a single plane].
    Ivanov VN; Vtiurin BM; Ivanova LF; Kondzhariia IuR
    Med Radiol (Mosk); 1983 Mar; 28(3):38-42. PubMed ID: 6835057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of combination of (252)Cf neutron intracavitary brachytherapy and external beam radiotherapy for 110 cervical cancer patients].
    Bu J; Li R; Song W; Cao JX; Wang YX
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):619-21. PubMed ID: 21122417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interstitial neutron therapy using flexible 252Cf sources].
    Vtiurin BM; Medvedev VS; Ivanov VN; Elisiutin GP; Petrovskaia GA
    Med Radiol (Mosk); 1984 Jun; 29(6):7-16. PubMed ID: 6738328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Californium-252 neutron curietherapy for advanced cervical cancer.
    Maruyama Y; Bell PR; Yoneda J; Van Nagell JR
    Oncology; 1982; 39(4):209-15. PubMed ID: 7088471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cervical cancer clearance after 252Cf neutron brachytherapy versus conventional photon brachytherapy.
    Maruyama Y; Muir W
    Am J Clin Oncol; 1984 Aug; 7(4):347-52. PubMed ID: 6741864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparison of tandem and Ovoids vs. tandem and ring for intracavitary gynecologic applications.
    Levin D; Menhel J; Rabin T; Pfeffer MR; Symon Z
    Med Dosim; 2008; 33(4):315-20. PubMed ID: 18973861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.